
Global High Purity Medical Grade Isosorbide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global High Purity Medical Grade Isosorbide market size was valued at US$ 65.7 million in 2024 and is forecast to a readjusted size of USD 80.9 million by 2031 with a CAGR of 2.8% during review period.
Pharmaceutical Grade Isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to cyclic sugar alcohols. It has good biocompatibility and biodegradability. In the pharmaceutical field, isosorbide and its derivatives are used to produce drugs for the treatment of cardiovascular diseases, with good drug activity and safety. At the same time, isosorbide is also an effective osmotic oral dehydration diuretic.
The global pharmaceutical-grade isosorbide market is entering a period of steady growth, and the compound annual growth rate is expected to reach 2.88% in the next five years. This trend is mainly driven by two aspects: first, the rising incidence of chronic diseases such as cardiovascular diseases and neurological diseases has driven the growth of demand for core APIs such as isosorbide dinitrate; second, the research and development of innovative drugs is hot, and its technical value as a chiral intermediate in the development of controlled-release preparations and targeted drugs is highlighted. At the same time, the strict standards of the global pharmaceutical industry for the purity and stability of APIs have further strengthened the market barriers and premium space for high-purity pharmaceutical-grade products. From the perspective of regional distribution, Europe and China dominate the global supply of pharmaceutical-grade isosorbide. Europe occupies most of the market share with its mature bio-based chemical industry chain. As an industry benchmark, Roquette, a French company, has long served the supply chain of multinational pharmaceutical companies by relying on continuous production processes and cGMP certification systems. China has risen rapidly through policy support and capacity upgrades. Local companies such as Yuteng Pharmaceuticals have broken through the bottleneck of high-purity purification technology and built a thousand-ton pharmaceutical-grade production line. Its cost advantage and localized service capabilities have gradually opened up the high-end market in Europe and the United States.
The main consumer market for pharmaceutical-grade products is relatively scattered, and there is demand in all countries around the world. Among them, the countries with greater demand include China, India, Japan, the United States, Europe and other developed pharmaceutical markets.
This report is a detailed and comprehensive analysis for global High Purity Medical Grade Isosorbide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global High Purity Medical Grade Isosorbide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Purity Medical Grade Isosorbide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High Purity Medical Grade Isosorbide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roquette, Yu Teng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
High Purity Medical Grade Isosorbide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
99.9%
99%
Market segment by Application
Cardiovascular Drugs
Dehydration Diuretics
Others
Major players covered
Roquette
Yu Teng
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Purity Medical Grade Isosorbide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High Purity Medical Grade Isosorbide, with price, sales quantity, revenue, and global market share of High Purity Medical Grade Isosorbide from 2020 to 2025.
Chapter 3, the High Purity Medical Grade Isosorbide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Purity Medical Grade Isosorbide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and High Purity Medical Grade Isosorbide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High Purity Medical Grade Isosorbide.
Chapter 14 and 15, to describe High Purity Medical Grade Isosorbide sales channel, distributors, customers, research findings and conclusion.
Pharmaceutical Grade Isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to cyclic sugar alcohols. It has good biocompatibility and biodegradability. In the pharmaceutical field, isosorbide and its derivatives are used to produce drugs for the treatment of cardiovascular diseases, with good drug activity and safety. At the same time, isosorbide is also an effective osmotic oral dehydration diuretic.
The global pharmaceutical-grade isosorbide market is entering a period of steady growth, and the compound annual growth rate is expected to reach 2.88% in the next five years. This trend is mainly driven by two aspects: first, the rising incidence of chronic diseases such as cardiovascular diseases and neurological diseases has driven the growth of demand for core APIs such as isosorbide dinitrate; second, the research and development of innovative drugs is hot, and its technical value as a chiral intermediate in the development of controlled-release preparations and targeted drugs is highlighted. At the same time, the strict standards of the global pharmaceutical industry for the purity and stability of APIs have further strengthened the market barriers and premium space for high-purity pharmaceutical-grade products. From the perspective of regional distribution, Europe and China dominate the global supply of pharmaceutical-grade isosorbide. Europe occupies most of the market share with its mature bio-based chemical industry chain. As an industry benchmark, Roquette, a French company, has long served the supply chain of multinational pharmaceutical companies by relying on continuous production processes and cGMP certification systems. China has risen rapidly through policy support and capacity upgrades. Local companies such as Yuteng Pharmaceuticals have broken through the bottleneck of high-purity purification technology and built a thousand-ton pharmaceutical-grade production line. Its cost advantage and localized service capabilities have gradually opened up the high-end market in Europe and the United States.
The main consumer market for pharmaceutical-grade products is relatively scattered, and there is demand in all countries around the world. Among them, the countries with greater demand include China, India, Japan, the United States, Europe and other developed pharmaceutical markets.
This report is a detailed and comprehensive analysis for global High Purity Medical Grade Isosorbide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global High Purity Medical Grade Isosorbide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global High Purity Medical Grade Isosorbide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Purity Medical Grade Isosorbide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High Purity Medical Grade Isosorbide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roquette, Yu Teng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
High Purity Medical Grade Isosorbide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
99.9%
99%
Market segment by Application
Cardiovascular Drugs
Dehydration Diuretics
Others
Major players covered
Roquette
Yu Teng
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Purity Medical Grade Isosorbide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High Purity Medical Grade Isosorbide, with price, sales quantity, revenue, and global market share of High Purity Medical Grade Isosorbide from 2020 to 2025.
Chapter 3, the High Purity Medical Grade Isosorbide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Purity Medical Grade Isosorbide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and High Purity Medical Grade Isosorbide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High Purity Medical Grade Isosorbide.
Chapter 14 and 15, to describe High Purity Medical Grade Isosorbide sales channel, distributors, customers, research findings and conclusion.
Table of Contents
72 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: High Purity Medical Grade Isosorbide by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.